- Home
- VTYX vs EBMT Comparison
VTYX vs EBMT Comparison
Compare VTYX & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- EBMT
- Stock Information
- Founded
- VTYX 2018
- EBMT 1922
- Country
- VTYX United States
- EBMT United States
- Employees
- VTYX N/A
- EBMT N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- EBMT Major Banks
- Sector
- VTYX Health Care
- EBMT Finance
- Exchange
- VTYX Nasdaq
- EBMT Nasdaq
- Market Cap
- VTYX 154.9M
- EBMT 141.1M
- IPO Year
- VTYX 2021
- EBMT N/A
- Fundamental
- Price
- VTYX $1.70
- EBMT $16.97
- Analyst Decision
- VTYX Buy
- EBMT
- Analyst Count
- VTYX 4
- EBMT 0
- Target Price
- VTYX $11.33
- EBMT N/A
- AVG Volume (30 Days)
- VTYX 1.5M
- EBMT 44.6K
- Earning Date
- VTYX 05-08-2025
- EBMT 07-22-2025
- Dividend Yield
- VTYX N/A
- EBMT 3.36%
- EPS Growth
- VTYX N/A
- EBMT 26.99
- EPS
- VTYX N/A
- EBMT 1.41
- Revenue
- VTYX N/A
- EBMT $82,271,000.00
- Revenue This Year
- VTYX N/A
- EBMT N/A
- Revenue Next Year
- VTYX N/A
- EBMT $4.97
- P/E Ratio
- VTYX N/A
- EBMT $12.04
- Revenue Growth
- VTYX N/A
- EBMT 0.06
- 52 Week Low
- VTYX $0.78
- EBMT $12.61
- 52 Week High
- VTYX $5.66
- EBMT $18.49
- Technical
- Relative Strength Index (RSI)
- VTYX 61.97
- EBMT 44.41
- Support Level
- VTYX $1.68
- EBMT $16.75
- Resistance Level
- VTYX $1.85
- EBMT $17.35
- Average True Range (ATR)
- VTYX 0.15
- EBMT 0.35
- MACD
- VTYX 0.04
- EBMT -0.10
- Stochastic Oscillator
- VTYX 67.05
- EBMT 14.97
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.